Tonghua Huikang Biopharmaceutical Co., Ltd.
-
Founded in:
2011-06-23 -
Country:
China -
Address:
No. 10, Yongkang Road, Chaoyang Town, Huinan County -
Tax NO.:
91220523574085680R -
Registered Funds:
80 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Insulin (porcine or bovine) |
Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.
More
Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues. |
0 | ||
| Glycerol |
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.
More
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues. |
1.4~1.8g | 56-81-5 | 62 |
| Phenol |
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.
More
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues. |
0.25g | 108-95-2 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Insulin (porcine or bovine) |
Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.
More
Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues. |
0 | ||
| Glycerol |
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.
More
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues. |
1.4~1.8g | 56-81-5 | 62 |
| Phenol |
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.
More
This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues. |
0.25g | 108-95-2 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ammothamnine |
It can reduce the level of DHBV-DNA in the serum of ducks infected with hepatitis B virus (DHBV) and has a protective effect on toxic liver damage in mice caused by CCL4 and galactosamine
More
It can reduce the level of DHBV-DNA in the serum of ducks infected with hepatitis B virus (DHBV) and has a protective effect on toxic liver damage in mice caused by CCL4 and galactosamine |
16837-52-8 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Organic Calcium Boron Zinc |
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis
More
Regulate bone metabolism, promote new bone formation, increase bone calcium deposition, and prevent and treat osteoporosis |
0 | ||
| Phosphorus |
Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis
More
Regulate calcium and phosphorus metabolism, prevent and treat osteoporosis |
7723-14-0 | 0 | |
| Inorganic perovskite quantum dots CSPBX3 (X is CL, BR, I halogen) |
Regulate bone metabolism, increase bone calcium deposition, and prevent osteoporosis
More
Regulate bone metabolism, increase bone calcium deposition, and prevent osteoporosis |
0 | ||
| Inorganic salt |
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.
More
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects. |
0 | ||
| Trace Elements |
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.
More
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects. |
0 | ||
| L-tert-Leucine |
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects.
More
This product contains a variety of active peptides for bone metabolism, which can regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, and have anti-inflammatory and analgesic effects. |
20859-02-3 | 0 | |
| Active peptides for bone metabolism |
Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic
More
Regulate bone metabolism, stimulate osteoblast proliferation, promote new bone formation, regulate calcium and phosphorus metabolism, increase bone calcium deposition, prevent and treat osteoporosis, anti-inflammatory, analgesic |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Prostaglandin E1 |
The intravenous alprostadil preparation with lipid microspheres as drug carriers is not easy to inactivate alprostadil due to the encapsulation of lipid microspheres. It has the targeted property of being easily distributed to damaged blood vessels, thereby playing the role of dilating blood vessels and inhibiting platelet aggregation.
More
The intravenous alprostadil preparation with lipid microspheres as drug carriers is not easy to inactivate alprostadil due to the encapsulation of lipid microspheres. It has the targeted property of being easily distributed to damaged blood vessels, thereby playing the role of dilating blood vessels and inhibiting platelet aggregation. |
745-65-3 | 14 |